Amarin Corp Plc (AMRN)

[Number sleven]

TCI1, I need to listen to that segment again. My take from memory. I think they were trying to show what happens in a market after physicians are properly educated about the value of the product. They talked about the current standards of the medical community. "Lower is better" The focus has been LDL. Vazkepa is targeting a different prevention pathway. I think the point was that once the European medical community is brought up to speed, the uptake should be similar.
Sleven,